Warning - We would like to draw your attention to the existence of false subscription forms usurping the identity of Karista. Please note that we never sign a subscription document in advance. If you have any doubts and before signing any form, please contact us.

READ MORE

Acticor Biotech, our clinical-stage biotechnology portfolio participation involved in the acute phase of thrombotic diseases, strengthens its leadership team and announced the appointment of Mr. Alain Munoz as Chairman of the Board of Directors, Mrs. Sophie Binay and Mr. Yannick Pletan as General Managers.

READ MORE

MoveUp specialises in remote digital care before and after orthopaedic and bariatric surgeries. By participating in the financing round Karista aims to help develop moveUp's solution and accelerate its international expansion - reinforcing its presence in the Netherlands, France, Germany and the UK, while exploring the US market.

READ MORE

In order to support its European development strategy in several investment sectors, Karista announces the appointment of Yvan-Michel Ehkirch as a new member of its Executive Board

READ MORE

63% of the companies active in Digital Health throughout Europe were created in the last 5 years. In respond to the rapid growth of the sector, Karista publishes for the first time a European mapping of Digital Health funds (known as “e-health”).

READ MORE

Karista invests in MyPL (My Personal Lifescope) increasing its financing to €1.8m. This transaction allows MyPL to drive the development of its personalized augmented medicine platform in France and internationally, and to carry out the first implementations in hospitals.

READ MORE

[Karista Story #1] Our Partner Yvan-Michel Ehkirch and Simon Tchedikian, co-founder of sevenhugs, describe together the technological, human and financial aspects of their shared story and the milestones they have been going through, from the first meeting to the sale of sevenhugs to Qorvo, a major telecommunications American company.

READ MORE

Vestack, a tech company which specializes in the design and off-site construction of structures made from bio-sourced materials, announces a €2.6 million first financing round. This financing round will enable Vestack to accelerate its production capacity as well as finance its research and development projects.

READ MORE

Exotrail reports full success of first-ever cubesat mission equipped with Hall-effect electric propulsion technology. This is a major milestone in the company's journey to become a space mobility leader. This success is strengthened by the extremely short development timeframe, with less than a year from design to delivery.

READ MORE

Acticor Biotech, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, including acute ischemic stroke, today announces the recruitment of the first patient of its phase 2 GARDEN study to treat COVID-19 _related acute respiratory distress syndrome (ARDS) with glenzocimab.

READ MORE